The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.
Liat Shargian-AlonOdelia AmitHanna BernstineRonit GurionAnat Gafter-GviliUri RozovskiOren PasvolskyGalit PeretsNetanel A HorowitzJabour HallounChava PerryIrit AviviPia RaananiMoshe YeshurunRon RamPublished in: European journal of haematology (2022)
Referring patients with chemotherapy-sensitive disease in PR directly to HCT is associated with better OS compared to those receiving additional lines of treatment.